Selected research
Industry Growth & Trends
Global Next Generation Sequencing (NGS) Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Next Generation Sequencing (NGS) Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Next Generation Sequencing (NGS) Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Next Generation Sequencing (NGS) Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Next Generation Sequencing (NGS) Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Next Generation Sequencing (NGS) Service market include CLC Bio, GATC biotech AG, Macrogen, BGI (Beijing Genomics Institute), Illumina, Life Technology Corporation, EMC Corporation, Dnastar and 454 Life Sciences Corporation (Roche), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Next Generation Sequencing (NGS) Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Next Generation Sequencing (NGS) Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Next Generation Sequencing (NGS) Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Next Generation Sequencing (NGS) Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Next Generation Sequencing (NGS) Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Next Generation Sequencing (NGS) Service Market by Company
CLC Bio
GATC biotech AG
Macrogen
BGI (Beijing Genomics Institute)
Illumina
Life Technology Corporation
EMC Corporation
Dnastar
454 Life Sciences Corporation (Roche)
Agilent Technologies
Biomatters, Ltd
Next Generation Sequencing (NGS) Service Segment by Type
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing
Next Generation Sequencing (NGS) Service Segment by Application
Whole-genome Sequencing
Exome Sequencing
Targeted Resequencing
De Novo Sequencing
RNA Sequencing
ChIP Sequencing
Methyl Sequencing
Others
Next Generation Sequencing (NGS) Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next Generation Sequencing (NGS) Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Next Generation Sequencing (NGS) Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next Generation Sequencing (NGS) Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Next Generation Sequencing (NGS) Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Targeted Sequencing & Resequencing
- Whole Genome Sequencing
- Whole Exome Sequencing
Applications
- Whole-genome Sequencing
- Exome Sequencing
- Targeted Resequencing
- De Novo Sequencing
- RNA Sequencing
- ChIP Sequencing
- Methyl Sequencing
- Others
Companies covered
- CLC Bio
- GATC biotech AG
- Macrogen
- BGI (Beijing Genomics Institute)
- Illumina
- Life Technology Corporation
- EMC Corporation
- Dnastar
- 454 Life Sciences Corporation (Roche)
- Agilent Technologies
- Biomatters, Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Next Generation Sequencing (NGS) Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Next Generation Sequencing (NGS) Service Market Size by Region (2021-2032)
- 1.4.1 Global Next Generation Sequencing (NGS) Service Market Size by Region (2021-2026)
- 1.4.2 Global Next Generation Sequencing (NGS) Service Market Size by Region (2027-2032)
- 1.5 Key Regions Next Generation Sequencing (NGS) Service Market Size (2021-2032)
- 1.5.1 North America Next Generation Sequencing (NGS) Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Next Generation Sequencing (NGS) Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Next Generation Sequencing (NGS) Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Next Generation Sequencing (NGS) Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Next Generation Sequencing (NGS) Service Market Size Growth Rate (2021-2032)
2 Next Generation Sequencing (NGS) Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Targeted Sequencing & Resequencing
- 2.1.2 Whole Genome Sequencing
- 2.1.3 Whole Exome Sequencing
- 2.2 Global Next Generation Sequencing (NGS) Service Market Size by Type
- 2.2.1 Global Next Generation Sequencing (NGS) Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Next Generation Sequencing (NGS) Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Next Generation Sequencing (NGS) Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Next Generation Sequencing (NGS) Service Market Size by Regions
- 2.3.1 North America Next Generation Sequencing (NGS) Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Next Generation Sequencing (NGS) Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Next Generation Sequencing (NGS) Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Next Generation Sequencing (NGS) Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Next Generation Sequencing (NGS) Service Market Size Breakdown by Type (2021-2026)
3 Next Generation Sequencing (NGS) Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Whole-genome Sequencing
- 3.1.2 Exome Sequencing
- 3.1.3 Targeted Resequencing
- 3.1.4 De Novo Sequencing
- 3.1.5 RNA Sequencing
- 3.1.6 ChIP Sequencing
- 3.1.7 Methyl Sequencing
- 3.1.8 Others
- 3.2 Global Next Generation Sequencing (NGS) Service Market Size by Application
- 3.2.1 Global Next Generation Sequencing (NGS) Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Next Generation Sequencing (NGS) Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Next Generation Sequencing (NGS) Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Next Generation Sequencing (NGS) Service Market Size by Regions
- 3.3.1 North America Next Generation Sequencing (NGS) Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Next Generation Sequencing (NGS) Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Next Generation Sequencing (NGS) Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Next Generation Sequencing (NGS) Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Next Generation Sequencing (NGS) Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Next Generation Sequencing (NGS) Service Industry Trends
- 4.2 Next Generation Sequencing (NGS) Service Industry Drivers
- 4.3 Next Generation Sequencing (NGS) Service Industry Opportunities and Challenges
- 4.4 Next Generation Sequencing (NGS) Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Next Generation Sequencing (NGS) Service Revenue (2021-2026)
- 5.2 Global Next Generation Sequencing (NGS) Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Next Generation Sequencing (NGS) Service Key Company Headquarters & Area Served
- 5.4 Global Next Generation Sequencing (NGS) Service Company, Product Type & Application
- 5.5 Global Next Generation Sequencing (NGS) Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Next Generation Sequencing (NGS) Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Next Generation Sequencing (NGS) Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Next Generation Sequencing (NGS) Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 CLC Bio
- 6.1.1 CLC Bio Company Information
- 6.1.2 CLC Bio Business Overview
- 6.1.3 CLC Bio Next Generation Sequencing (NGS) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 CLC Bio Next Generation Sequencing (NGS) Service Product Portfolio
- 6.1.5 CLC Bio Recent Developments
- 6.2 GATC biotech AG
- 6.2.1 GATC biotech AG Company Information
- 6.2.2 GATC biotech AG Business Overview
- 6.2.3 GATC biotech AG Next Generation Sequencing (NGS) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 GATC biotech AG Next Generation Sequencing (NGS) Service Product Portfolio
- 6.2.5 GATC biotech AG Recent Developments
- 6.3 Macrogen
- 6.3.1 Macrogen Company Information
- 6.3.2 Macrogen Business Overview
- 6.3.3 Macrogen Next Generation Sequencing (NGS) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Macrogen Next Generation Sequencing (NGS) Service Product Portfolio
- 6.3.5 Macrogen Recent Developments
- 6.4 BGI (Beijing Genomics Institute)
- 6.4.1 BGI (Beijing Genomics Institute) Company Information
- 6.4.2 BGI (Beijing Genomics Institute) Business Overview
- 6.4.3 BGI (Beijing Genomics Institute) Next Generation Sequencing (NGS) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 BGI (Beijing Genomics Institute) Next Generation Sequencing (NGS) Service Product Portfolio
- 6.4.5 BGI (Beijing Genomics Institute) Recent Developments
- 6.5 Illumina
- 6.5.1 Illumina Company Information
- 6.5.2 Illumina Business Overview
- 6.5.3 Illumina Next Generation Sequencing (NGS) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Illumina Next Generation Sequencing (NGS) Service Product Portfolio
- 6.5.5 Illumina Recent Developments
- 6.6 Life Technology Corporation
- 6.6.1 Life Technology Corporation Company Information
- 6.6.2 Life Technology Corporation Business Overview
- 6.6.3 Life Technology Corporation Next Generation Sequencing (NGS) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Life Technology Corporation Next Generation Sequencing (NGS) Service Product Portfolio
- 6.6.5 Life Technology Corporation Recent Developments
- 6.7 EMC Corporation
- 6.7.1 EMC Corporation Company Information
- 6.7.2 EMC Corporation Business Overview
- 6.7.3 EMC Corporation Next Generation Sequencing (NGS) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 EMC Corporation Next Generation Sequencing (NGS) Service Product Portfolio
- 6.7.5 EMC Corporation Recent Developments
- 6.8 Dnastar
- 6.8.1 Dnastar Company Information
- 6.8.2 Dnastar Business Overview
- 6.8.3 Dnastar Next Generation Sequencing (NGS) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Dnastar Next Generation Sequencing (NGS) Service Product Portfolio
- 6.8.5 Dnastar Recent Developments
- 6.9 454 Life Sciences Corporation (Roche)
- 6.9.1 454 Life Sciences Corporation (Roche) Company Information
- 6.9.2 454 Life Sciences Corporation (Roche) Business Overview
- 6.9.3 454 Life Sciences Corporation (Roche) Next Generation Sequencing (NGS) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 454 Life Sciences Corporation (Roche) Next Generation Sequencing (NGS) Service Product Portfolio
- 6.9.5 454 Life Sciences Corporation (Roche) Recent Developments
- 6.10 Agilent Technologies
- 6.10.1 Agilent Technologies Company Information
- 6.10.2 Agilent Technologies Business Overview
- 6.10.3 Agilent Technologies Next Generation Sequencing (NGS) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Agilent Technologies Next Generation Sequencing (NGS) Service Product Portfolio
- 6.10.5 Agilent Technologies Recent Developments
- 6.11 Biomatters, Ltd
- 6.11.1 Biomatters, Ltd Company Information
- 6.11.2 Biomatters, Ltd Business Overview
- 6.11.3 Biomatters, Ltd Next Generation Sequencing (NGS) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Biomatters, Ltd Next Generation Sequencing (NGS) Service Product Portfolio
- 6.11.5 Biomatters, Ltd Recent Developments
7 North America
- 7.1 North America Next Generation Sequencing (NGS) Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Next Generation Sequencing (NGS) Service Market Size by Country (2021-2026)
- 7.3 North America Next Generation Sequencing (NGS) Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Next Generation Sequencing (NGS) Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Next Generation Sequencing (NGS) Service Market Size by Country (2021-2026)
- 8.3 Europe Next Generation Sequencing (NGS) Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Next Generation Sequencing (NGS) Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Next Generation Sequencing (NGS) Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Next Generation Sequencing (NGS) Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Next Generation Sequencing (NGS) Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Next Generation Sequencing (NGS) Service Market Size by Country (2021-2026)
- 10.3 South America Next Generation Sequencing (NGS) Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Next Generation Sequencing (NGS) Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Next Generation Sequencing (NGS) Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Next Generation Sequencing (NGS) Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst